Details on COVID-19 testing before flying to the U.S. On January 5, at 12:01 ET, @CDCgov will require a negative COVID-19 test result (taken within 2 days of departure) or proof of recovery for all travelers two years and older to the United States on flights originating from Chi...
METHODS:We randomly assigned hospitalized adult patients with severe Covid-19 pneumonia in a 2:1 ratio to receive convalescent plasma or placebo. The primary outcome was the patient's clinical status 30 days after the int...
If the time is calculated from the day when the symptom of the infection started showing, then patients must wait for around 36 days to get a second swab test. "It's not yet known how infectious a person may be in the recovery phase," researchers warned. According to previous studies,...
Executives have become more trusting of what technology can do, and they are pushing ahead with digital transformation. They indicate they are planning for COVID-19 recovery to include investment in technologies such as AI, IoT, blockchain, and cloud. The benefits long extolled by technophiles ...
During the coronavirus disease 2019 (COVID-19) pandemic, a wave of rapid and collaborative drug discovery efforts took place in academia and industry, culminating in several therapeutics being discovered, approved and deployed in a 2-year time frame. This article summarizes the collective experience...
Cost reduction strategies for COVID-19 recovery Actions that companies are taking right now to address COVID-19 can have a major impact on their long-term competitiveness and performance. As such, it is crucial for decision-makers to understand how the crisis is unfolding from a business perspe...
Green COVID-19 recoveryindustrial decarbonisationpolicy packageEU green dealtechnology readinessThis paper explores which climate-friendly projects could be part of the COVID-19 recovery while jump-starting the transition of the European basic materials industry. Findings from a literature review on ...
https://www.mckinsey.com/industries/public-sector/our-insights/covid-19-and-student-learning-in-the-united-states-the-hurt-could-last-a-lifetime HOW CAN THIS CHAPTER BE USED? UNESCO, in collaboration with McKinsey and Company Introduction The problem The ...
A difficulty with obtaining adequately informed consent is that much information about COVID-19, including actual mortality risk and infectiousness after recovery, is still highly uncertain, and models have been rapidly adjusting since the early days of the pandemic. Uncertainty, however, does not pr...
The US's Food and Drug Administration (FDA) has authorized emergency use of the Ebola drug remdesivir for treating the coronavirus for people who are hospitalized with severe Covid-19. It appears to help shorten the recovery time for people who were seriously ill, but it did not significantly...